249 related articles for article (PubMed ID: 21115246)
1. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives.
Na Y; Nam JM
Bioorg Med Chem Lett; 2011 Jan; 21(1):211-4. PubMed ID: 21115246
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytotoxicity and topoisomerase inhibition properties of multifarious aminoalkylated indeno[1,2-c]isoquinolin-5,11-diones.
Ahn G; Schifano-Faux N; Goossens JF; Baldeyrou B; Couture A; Grandclaudon P; Lansiaux A; Ryckebusch A
Bioorg Med Chem Lett; 2011 Apr; 21(8):2259-63. PubMed ID: 21439821
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 4β-carbamoyl epipodophyllotoxins as potential antitumour agents.
Kamal A; Kumar BA; Suresh P; Juvekar A; Zingde S
Bioorg Med Chem; 2011 May; 19(9):2975-9. PubMed ID: 21489802
[TBL] [Abstract][Full Text] [Related]
4. New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.
Cho HJ; Jung MJ; Woo S; Kim J; Lee ES; Kwon Y; Na Y
Bioorg Med Chem; 2010 Feb; 18(3):1010-7. PubMed ID: 20093033
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of novel podophyllotoxin analogs.
Li J; Hua HM; Tang YB; Zhang S; Ohkoshi E; Lee KH; Xiao Zy
Bioorg Med Chem Lett; 2012 Jul; 22(13):4293-5. PubMed ID: 22658864
[TBL] [Abstract][Full Text] [Related]
6. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
Basnet A; Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jahng Y; Na Y; Cho WJ; Kwon Y; Lee CS; Lee ES
Bioorg Med Chem Lett; 2010 Jan; 20(1):42-7. PubMed ID: 19954977
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues.
Woo S; Kang DH; Nam JM; Lee CS; Ha EM; Lee ES; Kwon Y; Na Y
Eur J Med Chem; 2010 Sep; 45(9):4221-8. PubMed ID: 20619511
[TBL] [Abstract][Full Text] [Related]
8. Indeno[1,2-c]isoquinolin-5,11-diones conjugated to amino acids: Synthesis, cytotoxicity, DNA interaction, and topoisomerase II inhibition properties.
Ahn G; Lansiaux A; Goossens JF; Bailly C; Baldeyrou B; Schifano-Faux N; Grandclaudon P; Couture A; Ryckebusch A
Bioorg Med Chem; 2010 Nov; 18(22):8119-33. PubMed ID: 20961767
[TBL] [Abstract][Full Text] [Related]
9. 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
Thapa P; Karki R; Thapa U; Jahng Y; Jung MJ; Nam JM; Na Y; Kwon Y; Lee ES
Bioorg Med Chem; 2010 Jan; 18(1):377-86. PubMed ID: 19939682
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Thapa U; Thapa P; Karki R; Yun M; Choi JH; Jahng Y; Lee E; Jeon KH; Na Y; Ha EM; Cho WJ; Kwon Y; Lee ES
Eur J Med Chem; 2011 Aug; 46(8):3201-9. PubMed ID: 21601964
[TBL] [Abstract][Full Text] [Related]
11. An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.
Kamal A; Kumar BA; Suresh P; Shankaraiah N; Kumar MS
Bioorg Med Chem Lett; 2011 Jan; 21(1):350-3. PubMed ID: 21144748
[TBL] [Abstract][Full Text] [Related]
12. A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.
Patra N; De U; Kang JA; Kim JM; Ahn MY; Lee J; Jung JH; Chung HY; Moon HR; Kim HS
Eur J Pharmacol; 2011 May; 658(2-3):98-107. PubMed ID: 21376033
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activity of 4'-hydroxychalcone derivatives against Jurkat cells and their effects on mammalian DNA topoisomerase I.
Gul HI; Cizmecioglu M; Zencir S; Gul M; Canturk P; Atalay M; Topcu Z
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):804-7. PubMed ID: 18830876
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of rotenoid derivatives with cytotoxic and topoisomerase II inhibitory activities.
Sangthong S; Krusong K; Ngamrojanavanich N; Vilaivan T; Puthong S; Chandchawan S; Muangsin N
Bioorg Med Chem Lett; 2011 Aug; 21(16):4813-8. PubMed ID: 21741833
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y
Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety.
Thapa P; Karki R; Yun M; Kadayat TM; Lee E; Kwon HB; Na Y; Cho WJ; Kim ND; Jeong BS; Kwon Y; Lee ES
Eur J Med Chem; 2012 Jun; 52():123-36. PubMed ID: 22503656
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of new xanthone analogues and their biological activity test--cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study.
Woo S; Jung J; Lee C; Kwon Y; Na Y
Bioorg Med Chem Lett; 2007 Mar; 17(5):1163-6. PubMed ID: 17194586
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiproliferative activity of some ellipticine-like 11H-pyrido[a]carbazole derivatives.
Ferlin MG; Gia O; Dalla Via L
ChemMedChem; 2011 Oct; 6(10):1872-83. PubMed ID: 21826796
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 4β-N-polyaromatic substituted podophyllotoxins: DNA topoisomerase inhibition, anticancer and apoptosis-inducing activities.
Kamal A; Kumar BA; Suresh P; Agrawal SK; Chashoo G; Singh SK; Saxena AK
Bioorg Med Chem; 2010 Dec; 18(24):8493-500. PubMed ID: 21074444
[TBL] [Abstract][Full Text] [Related]
20. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.
Baviskar AT; Madaan C; Preet R; Mohapatra P; Jain V; Agarwal A; Guchhait SK; Kundu CN; Banerjee UC; Bharatam PV
J Med Chem; 2011 Jul; 54(14):5013-30. PubMed ID: 21644529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]